No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
279 (estimated)
Sponsor
Medical University of South Carolina · Other
Who this trial is looking for
This trial is looking for cancer survivors aged 18 and older who have symptoms of depression. Participants will use a mobile app called 'Moodivate' for about 12 weeks and answer questionnaires about their mood and app usage.
Are You a Good Fit for This Trial?
You may be able to join if
I am over 18 years old
I have been diagnosed with cancer
I have elevated depressive symptoms
I own a smartphone
I am willing to use a mobile app for my mood
I have a valid email or can receive text messages
I speak and understand English
You may not be able to join if
I have thoughts of suicide
I have severe cognitive impairment
I have been diagnosed with dementia
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
The purpose of this research study is to evaluate a mobile application (app) for depression treatment called "Moodivate" among cancer survivors. Moodivate was developed by our research team to assist with the treatment of depressed mood.
Participants will be randomly assigned to either download the mobile app, "Moodivate", or not. Approximately 2/3 of participants enrolled will receive the mobile…
The purpose of this research study is to evaluate a mobile application (app) for depression treatment called "Moodivate" among cancer survivors. Moodivate was developed by our research team to assist with the treatment of depressed mood.
Participants will be randomly assigned to either download the mobile app, "Moodivate", or not. Approximately 2/3 of participants enrolled will receive the mobile app and the remaining 1/3 will not.
All participants will complete electronic questionnaire measures throughout the study period. Questionnaires will assess symptoms of depression, as well as your experiences using Moodivate and participating in this trial. Participation in this study will take about 12 weeks, beginning today.
Participation in this study may help in the treatment of future cancer survivors. The greatest risks of this study include frustration, worsening of emotional distress, data breach, and/or loss of confidentiality. Alternative treatments include contacting your primary care provider or your oncology care team to discuss other available treatments for depressed mood.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Age \> 18 years
* ILLIC (as determined during manual chart review)
* Elevated depressive symptoms, defined as a score of ≥ 8 on the PHQ-9
* Current owner of an iOS- or Android-compatible smartphone
* Willingness to utilize a mobile app for the treatment of depressed mood (resp…
Inclusion Criteria:
* Age \> 18 years
* ILLIC (as determined during manual chart review)
* Elevated depressive symptoms, defined as a score of ≥ 8 on the PHQ-9
* Current owner of an iOS- or Android-compatible smartphone
* Willingness to utilize a mobile app for the treatment of depressed mood (response of "yes" on yes/no item)
* Have a valid e-mail address that is checked regularly or have regular access to text messages (to access follow-up assessments)
* English language fluency
Exclusion Criteria:
* Current suicidal ideation at study screening, defined as a response greater than or equal to 1 on item nine of the PHQ-9
* Severe cognitive impairment that precludes completion of informed consent. For the purposes of assessing eligibility, this criterion is operationalized as:
* Prior diagnosis of dementia, or Major Neurocognitive Disorder indicated either via self-report or in the EHR; or
* Self-report of cognitive difficulties that impair functional independence
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.